Subscribe
istock-652532896_filograph
filograph / iStockphoto.com
3 July 2018Big Pharma

Novartis launches Nerve platform to harness ‘data revolution’

Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.
Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.
Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.

More on this story

Americas
Novartis sells portions of Sandoz US portfolio to Aurobindo
6 September 2018   Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.
Asia-Pacific
Sanofi to launch €66m R&D hub in China
5 July 2018   France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug